Clinical Trial

Phase 2a Study of the Efficacy and Safety of TRX-100 in a Human Influenza A Challenge Model

Name: Phase 2a Study of the Efficacy and Safety of TRX-100 in a Human Influenza A Challenge Model — clinical trial record (NCT07503405)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This will be a randomized, double-blind, placebo-controlled proof of concept study to evaluate the prophylactic efficacy and safety of orally administered TRX-100 in healthy adults challenged with influenza A/France/759/2021 (H1N1) virus.

Trial Details

NCT Number	NCT07503405
Lead Sponsor	Traws Pharma, Inc.
Conditions	Influenza
Enrollment	165 participants
Start Date	2026-06
Primary Completion	2026-11 (estimated)
Study Completion	2027-04 (estimated)
Updated on ClinicalTrials.gov	2026-03-31